查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1559993

C 反應蛋白檢測市場報告：2030 年趨勢、預測與競爭分析

C Reactive Protein Testing Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

C反應蛋白檢測趨勢與預測

到 2030 年，全球 C 反應蛋白 (CRP) 檢測市場預計將達到 47 億美元，2024 年至 2030 年複合年成長率為 3.1%。該市場的主要驅動力是老年人口的增加、照護現場設備的日益採用以及醫療服務需求的增加。全球C反應蛋白檢測市場的未來前景廣闊，糖尿病、類風濕性關節炎、心血管疾病和發炎性腸道疾病市場蘊藏著機會。

  • Lucintel 預計免疫比濁法在預測期內仍將是最大的細分市場，因為它可以靈敏地測量各種 CRP 值。
  • 在這個市場中，由於心血管疾病的快速增加以及對心血管疾病診斷和監測的需求不斷成長，心血管疾病仍將是最大的細分市場。
  • 由於該地區發炎疾病的盛行率不斷上升、不健康的生活方式改變以及醫療保健支出較高，在預測期內，北美將繼續成為最大的地區。

C反應蛋白檢測市場的新興趨勢

C 反應蛋白 (CRP) 檢測市場正在見證幾個反映技術進步和醫療需求變化的關鍵趨勢。這些趨勢正在透過提高效率、準確性和可及性來塑造 CRP 測試的未來。

  • 高敏感性CRP檢測：高敏感性CRP檢測的廣泛使用使得更準確地檢測低水平發炎成為可能。這些測試為慢性病的早期診斷和監測提供了有價值的資訊，透過更有針對性的干涉措施改善患者的治療結果。
  • 就地檢驗：照護現場CRP 檢測設備的興起使得在各種醫療環境中進行快速、輕鬆的檢測成為可能。這些測試設備可提供即時結果，從而能夠及時做出臨床決策並改善初級和緊急醫療環境中的患者照護。
  • 數位健康整合：CRP 測試擴大與數位健康平台和電子健康記錄整合。這種整合支援更好的資料管理、即時監控和改進的護理協調，從而提高 CRP 測試的整體有效性。
  • 自動化測試解決方案：CRP 測試實驗室的自動化簡化了工作流程並提高了測試吞吐量。自動化系統透過減少手動錯誤、提高一致性和效率，使 CRP 測試更加可靠和擴充性。
  • 具有成本效益的解決方案：人們越來越有興趣開發具有成本效益的 CRP 測試解決方案，以提高可訪問性，尤其是在資源匱乏的環境中。經濟實惠的檢測和簡化的製造流程正在擴大 CRP 檢測的範圍並改善醫療保健公平性。

這些趨勢透過提高測試靈敏度、便利性以及與數位健康工具的整合正在重塑 CRP 測試市場。對自動化和經濟高效的解決方案的關注正在提高可及性和效率，推動患者照護和診斷準確性的進步。

C反應蛋白檢測市場的最新趨勢

C 反應蛋白 (CRP) 檢測市場的最新趨勢反映了技術的進步和對精確診斷工具日益成長的需求。這些發展正在提高各個地區 CRP 測試的能力和可近性。

  • 先進的檢測技術：引進高靈敏度CRP檢測和多重CRP檢測，提升診斷準確性。這些技術還可以檢測到較低的發炎，從而更詳細地了解發炎狀況。
  • 照護現場設備：新型照護現場CRP 測試設備正在變得流行，提供快速、方便的測試選項。這些設備在急診醫學和初級保健環境中特別有用，可快速提供結果以幫助立即進行臨床決策。
  • 實驗室自動化：實驗室 CRP 測試過程的自動化正在提高效率和吞吐量。自動化系統減少了人工錯誤，簡化了工作流程，並使 CRP 測試更加可靠且擴充性。
  • 數位健康整合：CRP 測試擴大與數位健康平台整合，以增強資料管理和即時監控。這種整合透過無縫資料共用支援更好的患者管理和協調護理。
  • 經濟實惠的測試解決方案：經濟高效的 CRP 測試解決方案的開發正在擴大訪問範圍，特別是在資源匱乏的環境中。負擔得起的檢測縮小了獲得醫療保健的差距，並提高了服務不足地區的診斷能力。

這些發展透過提高準確性、效率和可近性來推動 CRP 測試市場的發展。檢測技術、自動化和成本效益方面的創新正在改善患者照護並擴大 CRP 檢測的全球範圍。

C 反應蛋白檢測市場的策略性成長機會

C 反應蛋白 (CRP) 測試市場在各種應用中呈現多種成長機會。這些機會是由技術進步和醫療保健需求增加所推動的。

  • 醫院診斷：先進 CRP 檢測技術在醫院的擴展帶來了巨大的成長機會。診斷能力的提高將推動對先進 CRP 檢測解決方案的需求，以改善患者管理並支持更好的臨床結果。
  • 初級保健：初級保健中的照護現場CRP 檢測設備有成長機會。這些設備能夠快速評估發炎，改善患者照護並促進門診病人環境的及時干預。
  • 急診醫學：快速 CRP 檢測在急診醫學的應用正在擴大。可攜式、高效的 CRP 檢測解決方案在緊急醫療環境中具有成長潛力，因為快速結果有助於急性疾病的診斷和管理。
  • 研究與開發：發炎疾病研究的進展為 CRP 檢測創造了成長機會。先進的檢測技術和創新的檢測方法正在支持研究工作並推動臨床實驗室和實驗室對 CRP 檢測的需求。
  • 國際擴張：擴大新興市場 CRP 測試的覆蓋範圍帶來了成長機會。經濟實惠且易於使用的檢測解決方案可以彌補醫療保健取得方面的差距，並提高資源匱乏地區的診斷能力。

這些成長機會凸顯了 CRP 測試在各種醫療保健環境中的廣泛使用。技術進步和不斷成長的全球需求正在推動市場發展，從而提高診斷能力並改善患者照護。

C反應蛋白檢測市場的促進因素與挑戰

C反應蛋白（CRP）檢測市場受到各種技術、經濟和監管因素的影響。這些市場促進因素和挑戰影響診斷領域的市場成長、創新和可近性。

推動 C 反應蛋白檢測市場的因素包括：

1.技術進步：CRP 檢測技術的創新，例如高靈敏度檢測和照護現場設備，透過提高診斷準確性和便利性來推動市場成長。這些進步滿足了對更準確、更快速的發炎檢測日益成長的需求。

2.醫療需求不斷增加：由於全球醫療領域的擴張，對高可靠CRP檢測的需求不斷增加。醫療意識的提高和醫療基礎設施的擴大正在推動對先進診斷工具的需求，以支持市場的擴張和發展。

3. 與數位健康整合：CRP 測試與數位健康平台整合可改善資料管理和患者照護。增強的連接性和即時監控能力將有助於更好的臨床決策並推動市場成長。

4. 監管支援：支持性法律規範促進先進 CRP 測試技術的創新和採用。明確的指導方針和核准簡化了市場准入並確保提供高品質的診斷解決方案。

5. 具有成本效益的解決方案：開拓負擔得起的 CRP 測試選項可以增加市場的可及性，特別是在資源匱乏的環境中。具有成本效益的解決方案擴大了獲得護理的機會，提高了診斷能力，並解決了獲得護理方面的差異。

CRP 測試市場面臨的挑戰是：

1.先進技術高成本：先進CRP檢測技術的成本高可能會限制准入並影響市場滲透率。昂貴的設備和檢測可能會限制低收入地區和醫療機構的採用。

2. 複雜的法規環境：應對複雜的區域監管標準是一項挑戰。製造商必須遵守各種法規，這增加了營運成本並使市場進入和擴張工作變得更加複雜。

3. 經濟限制：經濟波動會影響 CRP 測試技術的價格和可用性。衛生系統的預算限制可能會影響購買決策並減緩經濟困難地區的市場成長。

技術進步、不斷成長的醫療需求以及與數位健康的融合等市場促進因素正在推動 CRP 檢測市場向前發展。然而，需要解決高技術成本、複雜的法規環境和經濟限制等挑戰，以充分發揮市場潛力並確保廣泛獲得先進的診斷解決方案。

分段C反應蛋白測試

本研究包括按檢測類型、應用和區域對全球 C 反應蛋白檢測進行的預測。

C反應蛋白檢測市場的國家展望

由於技術進步、快速診斷需求的增加以及各種區域趨勢，C 反應蛋白 (CRP) 檢測市場正在不斷發展。這一趨勢是由各種醫療系統對更準確、更有效的發炎標記測試的需求所推動的。

  • 美國：由於靈敏檢測和就地檢驗設備的進步，美國市場的 CRP 檢測正在強勁成長。這些創新使得能夠更快、更準確地檢測發炎，從而改善患者管理並支持個人化治療策略。
  • 中國：由於醫療保健和診斷投資的增加，中國顯著擴大了 CRP 檢測基礎設施。先進的 CRP 檢測技術在醫院和診所的整合正在提高全國的診斷能力和患者照護。
  • 德國：在德國，我們致力於透過引入更複雜的分析平台來提高 CRP 測試的準確性。這些趨勢是將先進診斷納入常規醫療實踐的更廣泛趨勢的一部分，旨在提高診斷準確性和患者治療結果。
  • 印度：在印度，由於認知度和可及性的提高，CRP 檢測市場正在快速成長。採用具有成本效益且易於使用的 CRP 檢測解決方案正在擴大檢測覆蓋範圍，特別是在農村和服務不足的地區，並改善整體醫療保健的可及性。
  • 日本：在日本，實驗室晶片技術和自動化的創新正在 CRP 測試方面取得進展。這些進步簡化了測試流程，縮短了周轉時間，並提高了臨床和研究環境中 CRP 測試的效率。

常問問題

Q1.市場規模為：

A1. 到 2030 年，全球 C 反應蛋白檢測市場預計將達到 47 億美元。

Q2.市場成長預測是多少：

A2. 2024年至2030年，全球C反應蛋白檢測市場預計將以3.1%的複合年成長率成長。

Q3.影響市場成長的主要促進因素是：

A3. 該市場的主要驅動力是老年人口的增加、照護現場設備的採用增加以及醫療服務需求的增加。

Q4.市場的主要細分市場是：

A4.C反應蛋白檢測市場前景廣闊，在糖尿病、類風濕性關節炎、心血管疾病和發炎性腸道疾病市場中蘊藏著機會。

Q5.市場的主要企業是：

A5.C 反應蛋白檢測的主要企業有：

  • Thermo Fisher Scientific
  • F. Hoffmann-La Roche
  • Danaher
  • Quest Diagnostics
  • Siemens Healthineers
  • Abbott
  • Merck KGaAA
  • Zoetis
  • Ortho Clinical Diagnostics
  • Getein Biotech

Q6.未來最大的細分市場是什麼？

A6.Lucintel 預計免疫比濁法在預測期內仍將是最大的細分市場，因為它可以靈敏地測量各種 CRP 水平。

Q7.未來五年預計哪個地區的市場成長最大？

A7. 由於該地區發炎疾病的流行、不健康的生活方式的改變和高額的醫療保健支出，在預測期內，北美將繼續成為最大的地區。

Q8. 可以客製化報告嗎？

A8. 是的，Lucintel 提供 10% 的客製化服務，無需額外付費。

目錄

第1章執行摘要

第2章 全球C反應蛋白檢測市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球C反應蛋白檢測市場趨勢（2018-2023）與預測（2024-2030）
  • 按檢測類型分類的全球 C 反應蛋白檢測市場
    • 酵素免疫分析法
    • 化學冷光免疫檢測
    • 免疫比濁法
    • 其他
  • 按應用分類的全球 C 反應蛋白檢測市場
    • 糖尿病
    • 類風濕性關節炎
    • 心血管疾病
    • 發炎性腸道疾病
    • 其他

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球C反應蛋白檢測市場（按地區）
  • 北美C反應蛋白檢測市場
  • 歐洲C反應蛋白檢測市場
  • 亞太C反應蛋白檢測市場
  • 其他地區C反應蛋白檢測市場

第5章 競爭分析

  • 產品系列分析
  • 業務整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 按檢測類型分類的全球 C 反應蛋白檢測市場成長機會
    • 全球 C 反應蛋白測試市場成長機會（按應用）
    • 全球 C 反應蛋白測試市場成長機會（按地區）
  • 全球C反應蛋白檢測市場的新趨勢
  • 戰略分析
    • 新產品開發
    • 全球 C 反應蛋白檢測市場的產能擴張
    • 全球C反應蛋白檢測市場的合併、收購與合資
    • 認證和許可

第7章主要企業概況

  • Thermo Fisher Scientific
  • F. Hoffmann-La Roche
  • Danaher
  • Quest Diagnostics
  • Siemens Healthineers
  • Abbott
  • Merck KGaAA
  • Zoetis
  • Ortho Clinical Diagnostics
  • Getein Biotech
簡介目錄

C Reactive Protein Testing Trends and Forecast

The future of the global C reactive protein testing market looks promising with opportunities in the diabetes, rheumatoid arthritis, cardiovascular disease, and inflammatory bowel disease markets. The global C reactive protein testing market is expected to reach an estimated $4.7 billion by 2030 with a CAGR of 3.1% from 2024 to 2030. The major drivers for this market are increasing geriatric population, growing adoption of point-of-care devices, and rising demand for healthcare services.

  • Lucintel forecasts that immunoturbidimetric assay will remain the largest segment over the forecast period as it provides high sensitivity for measuring a wide range of CRP levels.
  • Within this market, cardiovascular disease will remain the largest segment due to surge in cardiovascular diseases and growing need to diagnose and monitor cardiovascular diseases.
  • North America will remain the largest region over the forecast period due to growing prevalence of inflammatory diseases, change in unhealthy lifestyle, and high healthcare expenditure in the region.

Emerging Trends in the C Reactive Protein Testing Market

The C-Reactive Protein (CRP) testing market is experiencing several key trends that reflect advancements in technology and shifts in healthcare needs. These trends are shaping the future of CRP testing by enhancing efficiency, accuracy, and accessibility.

  • High-Sensitivity CRP Tests: Increasing use of high-sensitivity CRP tests enables more precise detection of low levels of inflammation. These tests provide valuable information for early diagnosis and monitoring of chronic conditions, improving patient outcomes through more targeted interventions.
  • Point-of-Care Testing: The rise of point-of-care CRP testing devices allows for rapid and convenient testing in various healthcare settings. These devices facilitate immediate results, enabling timely clinical decisions and enhancing patient care in both primary and emergency settings.
  • Integration with Digital Health: CRP testing is increasingly integrated with digital health platforms and electronic health records. This integration supports better data management, real-time monitoring, and improved coordination of care, enhancing the overall effectiveness of CRP testing.
  • Automated Testing Solutions: Automation in CRP testing laboratories is streamlining workflows and increasing testing throughput. Automated systems reduce manual errors, improve consistency, and enhance efficiency, making CRP testing more reliable and scalable.
  • Cost-Effective Solutions: There is a growing focus on developing cost-effective CRP testing solutions to increase accessibility, particularly in low-resource settings. Affordable tests and streamlined production processes are expanding the reach of CRP testing and improving healthcare equity.

These trends are reshaping the CRP testing market by enhancing test sensitivity, convenience, and integration with digital health tools. The emphasis on automation and cost-effective solutions is improving accessibility and efficiency, driving advancements in patient care and diagnostic accuracy.

Recent Developments in the C Reactive Protein Testing Market

Recent developments in the C-Reactive Protein (CRP) testing market reflect advancements in technology and increasing demand for precise diagnostic tools. These developments are enhancing the capabilities and accessibility of CRP testing across various regions.

  • Advanced Testing Technologies: The introduction of high-sensitivity and multiplex CRP assays is improving diagnostic accuracy. These technologies allow for the detection of lower levels of inflammation and provide more detailed insights into inflammatory conditions.
  • Point-of-Care Devices: New point-of-care CRP testing devices are becoming more prevalent, offering rapid and convenient testing options. These devices are particularly beneficial in emergency and primary care settings, providing quick results that aid in immediate clinical decisions.
  • Automation in Labs: The automation of CRP testing processes in laboratories is increasing efficiency and throughput. Automated systems reduce manual errors and streamline workflows, making CRP testing more reliable and scalable.
  • Integration with Digital Health: CRP testing is increasingly integrated with digital health platforms, enhancing data management and real-time monitoring. This integration supports better patient management and more coordinated care through seamless data sharing.
  • Affordable Testing Solutions: The development of cost-effective CRP testing solutions is expanding access, especially in low-resource settings. Affordable tests help bridge the gap in healthcare access, improving diagnostic capabilities in underserved areas.

These developments are advancing the CRP testing market by improving accuracy, efficiency, and accessibility. Innovations in testing technologies, automation, and cost-effectiveness are enhancing patient care and expanding the reach of CRP testing globally.

Strategic Growth Opportunities for C Reactive Protein Testing Market

The C-Reactive Protein (CRP) testing market presents several growth opportunities across various applications. These opportunities are driven by advancements in technology and increasing healthcare demands.

  • Hospital Diagnostics: The expansion of advanced CRP testing technologies in hospitals presents significant growth opportunities. Enhanced diagnostic capabilities improve patient management and support better clinical outcomes, driving demand for sophisticated CRP testing solutions.
  • Primary Care Settings: Point-of-care CRP testing devices in primary care settings offer opportunities for growth. These devices enable rapid inflammation assessment, improving patient care and facilitating timely interventions in outpatient environments.
  • Emergency Medicine: The use of rapid CRP testing in emergency medicine is expanding. Quick results help in diagnosing and managing acute conditions, presenting growth potential for portable and efficient CRP testing solutions in emergency settings.
  • Research and Development: Increasing research into inflammatory diseases creates growth opportunities for CRP testing. Advanced testing technologies and innovative assays support research efforts, driving demand for CRP tests in clinical and research laboratories.
  • Global Expansion: Expanding access to CRP testing in emerging markets offers growth opportunities. Affordable and accessible testing solutions can bridge gaps in healthcare access, improving diagnostic capabilities in low-resource regions.

These growth opportunities highlight the expanding applications of CRP testing across various healthcare settings. Advancements in technology and increasing global demand are driving the market, enhancing diagnostic capabilities and improving patient care.

C Reactive Protein Testing Market Driver and Challenges

The C-Reactive Protein (CRP) testing market is influenced by various technological, economic, and regulatory factors. These drivers and challenges impact market growth, innovation, and accessibility in the diagnostic sector.

The factors responsible for driving the c reactive protein testing market include:

1. Technological Advancements: Innovations in CRP testing technologies, such as high-sensitivity assays and point-of-care devices, drive market growth by enhancing diagnostic accuracy and convenience. These advancements meet the increasing demand for more precise and rapid inflammation detection.

2. Increasing Healthcare Demand: The growing global healthcare sector increases the need for reliable CRP testing. Rising awareness and expanding healthcare infrastructure drive demand for advanced diagnostic tools, supporting market expansion and development.

3. Integration with Digital Health: The integration of CRP testing with digital health platforms improves data management and patient care. Enhanced connectivity and real-time monitoring capabilities drive market growth by facilitating better clinical decision-making.

4. Regulatory Support: Supportive regulatory frameworks promote innovation and adoption of advanced CRP testing technologies. Clear guidelines and approvals streamline market entry and ensure the availability of high-quality diagnostic solutions.

5. Cost-Effective Solutions: The development of affordable CRP testing options enhances market accessibility, particularly in low-resource settings. Cost-effective solutions expand reach and improve diagnostic capabilities, addressing disparities in healthcare access.

Challenges in the c reactive protein testing market are:

1. High Cost of Advanced Technologies: The high cost of advanced CRP testing technologies can limit accessibility and impact market penetration. Expensive equipment and assays may restrict adoption in lower-income regions and healthcare settings.

2. Complex Regulatory Environment: Navigating complex and varying regulatory standards across regions poses challenges. Manufacturers must comply with diverse regulations, increasing operational costs and complicating market entry and expansion efforts.

3. Economic Constraints: Economic fluctuations can affect the affordability and availability of CRP testing technologies. Budget constraints in healthcare systems may impact purchasing decisions and slow market growth in economically challenged regions.

The drivers of technological advancements, increasing healthcare demand, and integration with digital health are propelling the CRP testing market forward. However, challenges such as high technology costs, complex regulatory environments, and economic constraints must be addressed to fully realize market potential and ensure widespread access to advanced diagnostic solutions.

List of C Reactive Protein Testing Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies C reactive protein testing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the C reactive protein testing companies profiled in this report include-

  • Thermo Fisher Scientific
  • F. Hoffmann-La Roche
  • Danaher
  • Quest Diagnostics
  • Siemens Healthineers
  • Abbott
  • Merck KGaAA
  • Zoetis
  • Ortho Clinical Diagnostics
  • Getein Biotech

C Reactive Protein Testing by Segment

The study includes a forecast for the global C reactive protein testing by assay type, application, and region.

C Reactive Protein Testing Market by Assay Type [Analysis by Value from 2018 to 2030]:

  • Enzyme-Linked Immunosorbent Assay
  • Chemiluminescence Immunoassay
  • Immunoturbidimetric Assay
  • Others

C Reactive Protein Testing Market by Application [Analysis by Value from 2018 to 2030]:

  • Diabetes
  • Rheumatoid Arthritis
  • Cardiovascular Disease
  • Inflammatory Bowel Disease
  • Others

C Reactive Protein Testing Market by Region [Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

Country Wise Outlook for the C Reactive Protein Testing Market

The C-Reactive Protein (CRP) testing market is evolving with advancements in technology, increasing demand for rapid diagnostics, and varying regional trends. These developments are driven by the need for more accurate and efficient inflammatory marker testing across different healthcare systems.

  • United States: The U.S. market has seen significant growth in CRP testing due to advancements in high-sensitivity assays and point-of-care testing devices. These innovations enable faster and more accurate detection of inflammation, supporting improved patient management and personalized treatment strategies.
  • China: In China, there has been a notable expansion in CRP testing infrastructure, driven by increased investments in healthcare and diagnostics. The integration of advanced CRP testing technologies in hospitals and clinics is improving diagnostic capabilities and patient care across the country.
  • Germany: Germany is focusing on enhancing the precision of CRP tests with the introduction of more sophisticated analytical platforms. These developments are part of a broader trend towards integrating advanced diagnostics into routine healthcare practices, aiming to improve diagnostic accuracy and patient outcomes.
  • India: In India, the CRP testing market is growing rapidly due to increased awareness and accessibility. The adoption of cost-effective and user-friendly CRP testing solutions is expanding the reach of these tests, particularly in rural and underserved areas, improving overall healthcare access.
  • Japan: Japan is advancing CRP testing with innovations in lab-on-a-chip technologies and automation. These advancements are streamlining testing processes, reducing turnaround times, and enhancing the efficiency of CRP tests in both clinical and research settings.

Features of the Global C Reactive Protein Testing Market

Market Size Estimates: C reactive protein testing market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: C reactive protein testing market size by assay type, application, and region in terms of value ($B).

Regional Analysis: C reactive protein testing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different assay types, applications, and regions for the C reactive protein testing market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the C reactive protein testing market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

FAQ

Q1. What is the C reactive protein testing market size?

Answer: The global C reactive protein testing market is expected to reach an estimated $4.7 billion by 2030.

Q2. What is the growth forecast for C reactive protein testing market?

Answer: The global C reactive protein testing market is expected to grow with a CAGR of 3.1% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the C reactive protein testing market?

Answer: The major drivers for this market are increasing geriatric population, growing adoption of point-of-care devices, and rising demand for healthcare services.

Q4. What are the major segments for C reactive protein testing market?

Answer: The future of the C reactive protein testing market looks promising with opportunities in the diabetes, rheumatoid arthritis, cardiovascular disease, and inflammatory bowel disease markets.

Q5. Who are the key C reactive protein testing market companies?

Answer: Some of the key C reactive protein testing companies are as follows:

  • Thermo Fisher Scientific
  • F. Hoffmann-La Roche
  • Danaher
  • Quest Diagnostics
  • Siemens Healthineers
  • Abbott
  • Merck KGaAA
  • Zoetis
  • Ortho Clinical Diagnostics
  • Getein Biotech

Q6. Which C reactive protein testing market segment will be the largest in future?

Answer: Lucintel forecasts that immunoturbidimetric assay will remain the largest segment over the forecast period as it provides high sensitivity for measuring a wide range of CRP levels.

Q7. In C reactive protein testing market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to growing prevalence of inflammatory diseases, change in unhealthy lifestyle, and high healthcare expenditure in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the C reactive protein testing market by assay type (enzyme-linked immunosorbent assay, chemiluminescence immunoassay, immunoturbidimetric assay, and others), application (diabetes, rheumatoid arthritis, cardiovascular disease, inflammatory bowel disease, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
  • Market Report

Table of Contents

1. Executive Summary

2. Global C Reactive Protein Testing Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global C Reactive Protein Testing Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global C Reactive Protein Testing Market by Assay Type
    • 3.3.1: Enzyme-Linked Immunosorbent Assay
    • 3.3.2: Chemiluminescence Immunoassay
    • 3.3.3: Immunoturbidimetric Assay
    • 3.3.4: Others
  • 3.4: Global C Reactive Protein Testing Market by Application
    • 3.4.1: Diabetes
    • 3.4.2: Rheumatoid Arthritis
    • 3.4.3: Cardiovascular Disease
    • 3.4.4: Inflammatory Bowel Disease
    • 3.4.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global C Reactive Protein Testing Market by Region
  • 4.2: North American C Reactive Protein Testing Market
    • 4.2.1: North American C Reactive Protein Testing Market by Assay Type: Enzyme-Linked Immunosorbent Assay, Chemiluminescence Immunoassay, Immunoturbidimetric Assay, and Others
    • 4.2.2: North American C Reactive Protein Testing Market by Application: Diabetes, Rheumatoid Arthritis, Cardiovascular Disease, Inflammatory Bowel Disease, and Others
  • 4.3: European C Reactive Protein Testing Market
    • 4.3.1: European C Reactive Protein Testing Market by Assay Type: Enzyme-Linked Immunosorbent Assay, Chemiluminescence Immunoassay, Immunoturbidimetric Assay, and Others
    • 4.3.2: European C Reactive Protein Testing Market by Application: Diabetes, Rheumatoid Arthritis, Cardiovascular Disease, Inflammatory Bowel Disease, and Others
  • 4.4: APAC C Reactive Protein Testing Market
    • 4.4.1: APAC C Reactive Protein Testing Market by Assay Type: Enzyme-Linked Immunosorbent Assay, Chemiluminescence Immunoassay, Immunoturbidimetric Assay, and Others
    • 4.4.2: APAC C Reactive Protein Testing Market by Application: Diabetes, Rheumatoid Arthritis, Cardiovascular Disease, Inflammatory Bowel Disease, and Others
  • 4.5: ROW C Reactive Protein Testing Market
    • 4.5.1: ROW C Reactive Protein Testing Market by Assay Type: Enzyme-Linked Immunosorbent Assay, Chemiluminescence Immunoassay, Immunoturbidimetric Assay, and Others
    • 4.5.2: ROW C Reactive Protein Testing Market by Application: Diabetes, Rheumatoid Arthritis, Cardiovascular Disease, Inflammatory Bowel Disease, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global C Reactive Protein Testing Market by Assay Type
    • 6.1.2: Growth Opportunities for the Global C Reactive Protein Testing Market by Application
    • 6.1.3: Growth Opportunities for the Global C Reactive Protein Testing Market by Region
  • 6.2: Emerging Trends in the Global C Reactive Protein Testing Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global C Reactive Protein Testing Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global C Reactive Protein Testing Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Thermo Fisher Scientific
  • 7.2: F. Hoffmann-La Roche
  • 7.3: Danaher
  • 7.4: Quest Diagnostics
  • 7.5: Siemens Healthineers
  • 7.6: Abbott
  • 7.7: Merck KGaAA
  • 7.8: Zoetis
  • 7.9: Ortho Clinical Diagnostics
  • 7.10: Getein Biotech